COVID booster vaccine candidate raises antibody response against omicron: Moderna

Moderna said its bivalent COVID booster candidate that targets omicron demonstrates "superior antibody response" against the variant one month after it is given.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.